LiverUnit_VallHebron retweeted
🟠 La #AEEH avala el 2º 'Barcelona International Workshop on Clinical Trials in MASH cACLD/cirrhosis'
👥El 26 de mayo, este encuentro científico de alto nivel reunirá en Barcelona a líderes internacionales en hepatología para debatir sobre selección de pacientes, endpoints y nuevas terapias en #MASH y #cirrosis. Entre ellos, nuestro presidente Rafael Bañares o expertos como @mromerogomez @JuanAbraldes @pericas_jm @docberza o @AleksanderKrag.
🧑💻 Inscripción gratis aquí:🔗vallhebron.com/en/node/30869
And dinner of the Spanish Portal Hypertension (Fraternity) Group
👏👏👏🔝🔝🔝
@AEEH2026
@AEEHLiver @BavenoCoop @CIBER_ISCIII @VHIR_
Many fantastic scientific activity from members of our @LHuvh during the #AEEH2026
Congratulations to the team
👏👏👏
@AEEHLiver @CIBER_ISCIII @VHIR_
3
196
LiverUnit_VallHebron retweeted
💡 The ANTICIPATE-NASH models outperform histology in predicting clinical events in advanced MASLD, enabling better patient risk stratification for clinical care and trial selection. Read the full study here: ow.ly/27TO50Y7EO7
🖋️ @JuanAbraldes
Finally our @LHuvh @JuanAbraldes @salvopetta @GileadSciences paper on @AGA_Gastro showing that #ANTICIPATE-NASH predicts and stratifies clinicals events ⬆️⬆️better than #histology #TLM25
@BavenoCoop @VHIR_ @CIBER_ISCIII @AASLDtweets
sciencedirect.com/science/ar…
Delayed but not forgotten, celebrating ending the residence with our @LHuvh senior residents in hepatology.
Some will stay, some will go away, but remembered will be all.
@vallhebron @VHIR_ @AEEHLiver
3
244
Excelent editorial by @ldcastera in @AGA_Gastro about our coming paper @LHuvh
@JuanAbraldes @salvopetta showing that #ANTICIPATE-NASH predicts and stratifies clinicals events better than #histology
@BavenoCoop @VHIR_ @CIBER_ISCIII
gastrojournal.org/article/S0…
The 25 kPa for #CSPH is valid, buy the #ANTICIPATE+/- NASH 75% is better. A new ruling in criterion for CSPH by the @BavenoCoop:
Refining the Baveno VII criteria for clinically significant portal hypertension- Journal of Hepatology
journal-of-hepatology.eu/art…
@LHuvh @VHIR_ @ciberehd
LiverUnit_VallHebron retweeted
Original Article
Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death
Vutien et al.
#LiverX
tinyurl.com/4v7r4cev
LiverUnit_VallHebron retweeted
Ciao Jaume, goodbye cariño mio. You have been such a special and wonderful man and I will love you forever.
The Liver Unit @LHuvh of HUVH @vallhebron wants to pay tribute to Jaime Bosch. A model for hepatologists and a true friend . The portal hypertension gang @BavenoCoop is now orphan.
With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend.
Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.
10
546
LiverUnit_VallHebron retweeted
New research - Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
thelancet.com/journals/langa…
#LiverTwitter #MedTwitter
Mar Riveiro @mar_riveiro from our @LHuvh preventing a multi center study on CDKi-induced liver injury
2
188
Juanma Pericàs from our @LHuvh presenting today in a MASLD therapy session at #EASLCongress
LiverUnit_VallHebron retweeted
📊 Validation of Baveno VII criteria for non-invasive diagnosis of clinically significant portal hypertension: systematic review and individual patient data meta-analysis
#POSTER WED-512-YI by Juan Bañares (@vallhebron) #EASL2025 @ef_clif @easlnews

































